Strides Pharma Science's Stock Reaches 52-Week High, Recognized as 'Buy' by MarketsMOJO

Strides Pharma Science, a midcap pharmaceutical company, has been making waves in the stock market with its recent performance. On October 3rd, the company's stock price reached a 52-week high, hitting Rs.1462. This positive momentum has been recognized by MarketsMOJO, who have given the stock a 'Buy' call. Strides Pharma Science has also been listed as part of Momentumnow Stocks on MarketsMOJO since April 3rd, 2024. This further solidifies the company's strong performance in the market. In terms of price performance, Strides Pharma Science has outperformed the sector by 5.12% and has been on a consecutive gain for the last 2 days, with a 4.54% increase in returns during this period. The stock also opened with a gain of 2.35% today and touched an intraday high of Rs.1462, showing its strong upward trend. Moreover, Strides Pharma Science is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. In comparison to the Sensex performance, Strides Pharma Science has shown an impressive 1-year performance of 195.67%, while the Sensex has only seen a 27.81% increase. This showcases the company's strong growth and potential in the pharmaceutical industry. With its recent achievements and positive performance, Strides Pharma Science is definitely a company to watch out for in the midcap pharmaceutical sector. Investors can consider adding this stock to their portfolio for potential long-term gains.